+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
CONCORD CONCORD

Concord Drugs Share Price

₹63.35 -2.64 (-4%)
New 52W Low in past week

30 Oct, 2026 4:01 PM (IST)

Concord Drugs live price: ₹63.35. It opened at ₹66 vs previous close ₹66; intraday high/low: ₹66/₹63. The 50 & 200 DMA stand at ₹72.20/₹73.40.

Concord Drugs Performance

  • Today's Low
  • ₹63
  • Today's High
  • ₹66
  • 52 Week Low
  • ₹60
  • 52 Week High
  • ₹93
  • Open Price₹66
  • Previous Close₹66
  • Volume1,732
  • 50 DMA₹72.20
  • 100 DMA₹74.00
  • 200 DMA₹73.40

Concord Drugs Chart

Investment Returns

  • Over 1 Month -15%
  • Over 3 Month -14.38%
  • Over 6 Month -25.58%
  • Over 1 Year -8.24%

Smart Investing Starts Here Start SIP with Concord Drugs for Steady Growth!

Invest Now

Concord Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 40.7
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 84
  • P/B Ratio
  • 1.7
  • Average True Range
  • 5.1
  • EPS
  • 1.6
  • Dividend Yield
  • 0
  • MACD Signal
  • -3
  • RSI
  • 33.88
  • MFI
  • 31.13

Latest Stock News Updates

Concord Drugs Ltd - 538965 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Annual general meeting -Scrutinizer''s Report

Concord Drugs Ltd - 538965 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Summary Proceedings of AGM

Concord Drugs Ltd - 538965 - Closure of Trading Window

Closure of trading Window

Concord Drugs Financials

Concord Drugs Technicals

EMA & SMA

Current Price
₹63.35
-2.64 (-4%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹68.80
  • 50 Day
  • ₹72.20
  • 100 Day
  • ₹74.00
  • 200 Day
  • ₹73.40

Resistance and Support

64.12 Pivot Speed
  • R3 68.30
  • R2 67.20
  • R1 65.40
  • S1 62.40
  • S2 61.20
  • S3 59.40

Concord Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-10 Quarterly Results
2026-05-27 Audited Results
2026-02-14 Quarterly Results
2025-11-13 Quarterly Results
2025-08-08 Quarterly Results

Concord Drugs Shareholding Pattern

54.92%
45.08%
0%

About Concord Drugs

Concord Drugs are prepared with generally accepted accounting principles in India under the historical cost convention and on an accrual basis of accounting. View More
  • NSE Symbol
  • CONCORD
  • BSE Symbol
  • 538965
  • ISIN
  • INE858L01010

Similar Stocks to Concord Drugs

Concord Drugs FAQs

Concord Drugs share price is ₹63 As on 01 November, 2026 | 09:53

The Market Cap of Concord Drugs is ₹83.5 Cr As on 01 November, 2026 | 09:53

The P/E ratio of Concord Drugs is 40.7 As on 01 November, 2026 | 09:53

The PB ratio of Concord Drugs is 1.7 As on 01 November, 2026 | 09:53

The 52 week High & Low of Concord Drugs is ₹92.5/₹60 respectively As on 01 November, 2026 | 09:53

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23